IGC Pharma, Inc. (IGC)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 03-31. Amounts in USD.

Revenue TTM

0 500K 1M 1.5M Q2 '25: 1.2M Q3 '25: 1.2M Q4 '25: 1.3M Q1 '26: 1.3M Q2 '26: 1.1M Q3 '26: 1.2M Q4 '26: 1.2M Q1 '27: 1.1M Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

Gross Profit TTM

0 250K 500K 750K Q2 '25: 665K Q3 '25: 636K Q4 '25: 619K Q1 '26: 610K Q2 '26: 511K Q3 '26: 451K Q4 '26: 352K Q1 '27: 246K Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

Operating Income TTM

-12M -8M -4M 0 4M 8M 12M Q2 '25: -9.3M Q3 '25: -8.2M Q4 '25: -7.4M Q1 '26: -7M Q2 '26: -8.1M Q3 '26: -9.2M Q4 '26: -10.2M Q1 '27: -11.1M Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

Net Income TTM

-15M -10M -5M 0 5M 10M 15M Q2 '25: -12.6M Q3 '25: -8.8M Q4 '25: -7.1M Q1 '26: -6.3M Q2 '26: -6.4M Q3 '26: -5.3M Q4 '26: -6.5M Q1 '27: -7.9M Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

Cost of Revenue TTM

0 300K 600K 900K Q2 '25: 518K Q3 '25: 600K Q4 '25: 652K Q1 '26: 717K Q2 '26: 595K Q3 '26: 748K Q4 '26: 834K Q1 '27: 877K Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

Operating Cash Flow TTM

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q2 '25: -4.9M Q3 '25: -4.6M Q4 '25: -4.8M Q1 '26: -4.5M Q2 '26: -5.5M Q3 '26: -5.5M Q4 '26: -5.9M Q1 '27: -5.9M Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

Free Cash Flow TTM

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q2 '25: -5M Q3 '25: -4.7M Q4 '25: -4.9M Q1 '26: -4.5M Q2 '26: -5.6M Q3 '26: -5.5M Q4 '26: -6M Q1 '27: -5.9M Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 35M 70M 105M Q1 '25: 72.8M Q2 '25: 76M Q3 '25: 77.6M Q4 '25: 79.7M Q1 '26: 83M Q2 '26: 90.5M Q4 '26: 98.2M Q1 '27: 100.3M Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q4 '26 Q1 '27

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.21 -0.14 -0.07 0.00 0.07 0.14 0.21 Q2 '25: -0.18 Q3 '25: -0.11 Q4 '25: -0.09 Q1 '26: -0.08 Q2 '26: -0.08 Q3 '26: -0.07 Q4 '26: -0.07 Q1 '27: -0.08 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26 Q3 '26 Q4 '26 Q1 '27

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.